Gordon Dunn insider trades: Quoin Pharmaceuticals (QNRX) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Gordon reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 23, 2024 | QNRX | ↑ Buy | 122,221 | $0.45 | $55K | Direct | Dec 27, 2024 (4d) |
| Sep 10, 2024 | QNRX | ↑ Buy | 28,856 | $0.80 | $23K | Direct | Sep 11, 2024 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other QNRX insiders
Open-market trades in the last 12 months
About Gordon Dunn's insider trades
Gordon Dunn is Chief Financial Officer at Quoin Pharmaceuticals (QNRX). Since Sep 10, 2024, Gordon has reported 2 open-market purchases worth $78K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (2 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every QNRX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.